Small Molecule API Market Is Likely to Grow at an Impressive CAGR of 4.9% by 2027: Boehringer Ingelheim GmbH, GlaxoSmithKline PLC
A FMI study titled "Small Mole API Market" has highlighted that small molecule APIs continue to dominate the pharmaceutical market with fast U.S. FDA approvals for small molecule APIs in 2017. Small molecules are chemical substances composed of two or more atoms with molecular weight of less than 900 Dalton. In this report, the small molecule API segment is further categorized into standard API and high potency APIs. The U.S. FDA approved 34 new small molecule API entities in 2017....
View full press release